BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 25771108)

  • 1. Synthesis, crystal structure and biological evaluation of substituted quinazolinone benzoates as novel antituberculosis agents targeting acetohydroxyacid synthase.
    Lu W; Baig IA; Sun HJ; Cui CJ; Guo R; Jung IP; Wang D; Dong M; Yoon MY; Wang JG
    Eur J Med Chem; 2015 Apr; 94():298-305. PubMed ID: 25771108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of novel acetohydroxyacid synthase inhibitors as active agents against Mycobacterium tuberculosis by virtual screening and bioassay.
    Wang D; Zhu X; Cui C; Dong M; Jiang H; Li Z; Liu Z; Zhu W; Wang JG
    J Chem Inf Model; 2013 Feb; 53(2):343-53. PubMed ID: 23316686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of potent chemical antituberculosis agents targeting Mycobacterium tuberculosis acetohydroxyacid synthase.
    Jung IP; Ha NR; Lee SC; Ryoo SW; Yoon MY
    Int J Antimicrob Agents; 2016 Sep; 48(3):247-58. PubMed ID: 27451857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of ssDNA aptamers as potent inhibitors of Mycobacterium tuberculosis acetohydroxyacid synthase.
    Baig IA; Moon JY; Lee SC; Ryoo SW; Yoon MY
    Biochim Biophys Acta; 2015 Oct; 1854(10 Pt A):1338-50. PubMed ID: 25988243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and ex vivo activity of new derivatives of acetohydroxyacid synthase inhibitors against Mycobacterium tuberculosis and non-tuberculous mycobacteria.
    Sohn H; Lee KS; Ko YK; Ryu JW; Woo JC; Koo DW; Shin SJ; Ahn SJ; Shin AR; Song CH; Jo EK; Park JK; Kim HJ
    Int J Antimicrob Agents; 2008 Jun; 31(6):567-71. PubMed ID: 18337064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of acetohydroxyacid synthase from Mycobacterium tuberculosis and the identification of its new inhibitor from the screening of a chemical library.
    Choi KJ; Yu YG; Hahn HG; Choi JD; Yoon MY
    FEBS Lett; 2005 Aug; 579(21):4903-10. PubMed ID: 16111681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rational design based on bioactive conformation analysis of pyrimidinylbenzoates as acetohydroxyacid synthase inhibitors by integrating molecular docking, CoMFA, CoMSIA, and DFT calculations.
    He YZ; Li YX; Zhu XL; Xi Z; Niu C; Wan J; Zhang L; Yang GF
    J Chem Inf Model; 2007; 47(6):2335-44. PubMed ID: 17887745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the in vitro and intracellular efficacy of new monosubstituted sulfonylureas against extensively drug-resistant tuberculosis.
    Wang D; Pan L; Cao G; Lei H; Meng X; He J; Dong M; Li Z; Liu Z
    Int J Antimicrob Agents; 2012 Nov; 40(5):463-6. PubMed ID: 22867883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological evaluation of phaitanthrin congeners as anti-mycobacterial agents.
    Kamal A; Reddy BV; Sridevi B; Ravikumar A; Venkateswarlu A; Sravanthi G; Sridevi JP; Yogeeswari P; Sriram D
    Bioorg Med Chem Lett; 2015 Sep; 25(18):3867-72. PubMed ID: 26253635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sulfonylureas have antifungal activity and are potent inhibitors of Candida albicans acetohydroxyacid synthase.
    Lee YT; Cui CJ; Chow EW; Pue N; Lonhienne T; Wang JG; Fraser JA; Guddat LW
    J Med Chem; 2013 Jan; 56(1):210-9. PubMed ID: 23237384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological evaluation of nonsymmetrical aromatic disulfides as novel inhibitors of acetohydroxyacid synthase.
    Li ZS; Wang WM; Lu W; Niu CW; Li YH; Li ZM; Wang JG
    Bioorg Med Chem Lett; 2013 Jul; 23(13):3723-7. PubMed ID: 23726033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of some novel AHAS inhibitors via molecular docking and virtual screening approach.
    Wang JG; Xiao YJ; Li YH; Ma Y; Li ZM
    Bioorg Med Chem; 2007 Jan; 15(1):374-80. PubMed ID: 17049866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of inhibitors targeting polyketide synthase 13 of Mycobacterium tuberculosis as antituberculosis drug leads.
    Wang X; Zhao W; Wang B; Ding W; Guo H; Zhao H; Meng J; Liu S; Lu Y; Liu Y; Zhang D
    Bioorg Chem; 2021 Sep; 114():105110. PubMed ID: 34175719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemical synthesis, in vitro acetohydroxyacid synthase (AHAS) inhibition, herbicidal activity, and computational studies of isatin derivatives.
    Wang J; Tan H; Li Y; Ma Y; Li Z; Guddat LW
    J Agric Food Chem; 2011 Sep; 59(18):9892-900. PubMed ID: 21838297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel amide and sulphonamide derivatives of 6-(piperazin-1-yl)phenanthridine as potent Mycobacterium tuberculosis H37Rv inhibitors.
    Naidu KM; Nagesh HN; Singh M; Sriram D; Yogeeswari P; Gowri Chandra Sekhar KV
    Eur J Med Chem; 2015 Mar; 92():415-26. PubMed ID: 25590862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro efficacy of acetohydroxyacid synthase inhibitors against clinical strains of Mycobacterium tuberculosis isolated from a hospital in Beijing, China.
    Dong M; Wang D; Jiang Y; Zhao L; Yang C; Wu C
    Saudi Med J; 2011 Nov; 32(11):1122-6. PubMed ID: 22057598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and molecular docking study of novel triazole-quinazolinone hybrids as antimalarial and antitubercular agents.
    Mhetre UV; Haval NB; Bondle GM; Rathod SS; Choudhari PB; Kumari J; Sriram D; Haval KP
    Bioorg Med Chem Lett; 2024 Aug; 108():129800. PubMed ID: 38763480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and synthesis of 11α-substituted bile acid derivatives as potential anti-tuberculosis agents.
    Pore VS; Divse JM; Charolkar CR; Nawale LU; Khedkar VM; Sarkar D
    Bioorg Med Chem Lett; 2015 Oct; 25(19):4185-90. PubMed ID: 26299346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of novel tetrahydrothieno[2,3-c]pyridine-3-carboxamide based Mycobacterium tuberculosis pantothenate synthetase inhibitors: molecular hybridization from known antimycobacterial leads.
    Samala G; Devi PB; Nallangi R; Sridevi JP; Saxena S; Yogeeswari P; Sriram D
    Bioorg Med Chem; 2014 Mar; 22(6):1938-47. PubMed ID: 24565972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery and development of novel salicylate synthase (MbtI) furanic inhibitors as antitubercular agents.
    Chiarelli LR; Mori M; Barlocco D; Beretta G; Gelain A; Pini E; Porcino M; Mori G; Stelitano G; Costantino L; Lapillo M; Bonanni D; Poli G; Tuccinardi T; Villa S; Meneghetti F
    Eur J Med Chem; 2018 Jul; 155():754-763. PubMed ID: 29940465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.